Navigation Links
Monkeys Respond To HIV Treatment

US based researchers are reported to identified two drugs meant for treating HIV patients also served to protect monkeys from contracting the AIDS virus. // As to whether the same can be applied to human beings also has not yet been confirmed, even though it may be possible.

Rhesus monkeys were experimented upon by the Centers for Disease and Prevention’s Dr. Walid Heneine, through injecting them with a version of the Truvada, manufactured by Gilead Sciences. This pill is a combination of Emtriva, or emtracitibine and Viread, or tenofovir. The combination has not yet cured a human being from the HIV infection, even though it helps in maintaining the existing state of health. After the injection, the monkeys were exposed continuously for 14 days to SHIV, a human-monkey AIDS virus.

Injections were also administered on a daily basis to the six experimental animals. None of the animals contracted the AIDS virus. There is a possibility that potent antiretrovirals administered before being exposed to HIV may protect a human being from AIDS, according to the results of the experiment, even though this may only be for a temporary period. The HIV virus is reported to be wrecking devastation among developing nations.

The US President has however recommended abstinence as the best way of stopping the disease, while those in the medical field have called for more practical methods to halt the spread of the disease. Even among the HIV virus, the A clade variety is reported to be less deadly than the D type, which brought about death more rapidly. There are a total 40 million people in this world who are HIV positive, and the developing world, particularly Africa accounts for most of this.
'"/>




Page: 1

Related medicine news :

1. Monkeys offer genetic clues to adult blindness
2. Urban Monkeys Source Of Virus Infections
3. Drug Company Admits Knowledge Of Side Effects In Monkeys
4. HIV Vaccine for Monkeys Increases Survival Rates
5. Effectiveness of Potential Bird flu Vaccine to be Tested on Monkeys
6. Acute Gastroenteritis Responds To Treatment With Either Gatorade Or Pedialyte
7. Study Highlights How Bacteria Respond To Changes In Environment
8. Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat
9. Immigrants Who Responded After 9/11 Lack Health Care
10. Responders On 9/11 Face Health Risks
11. Stubborn Ulcerative Colitis Responds to Arthritis Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: